Intelligence / Healthtech / New Clinical Trials / Cajal Therapeutics Inc.
Clinicaltrial registered28 Oct 2026
Cajal Therapeutics Inc.
28 Oct 2026: Trial registered · Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 28 Oct 2026
- Title
- Study of CTX001 in Adults With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease
- Conditions
- Chronic Kidney Disease, Anemia
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Countries
- Australia
- Country
- Australia
- Reference
- NCT07901933
- Location
- Australia
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Cajal Therapeutics Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Australia
New Clinical Trials
18 NovChengdu Zenitar Biomedical Technology Co., Ltdtrial registered · A Phase I Clinical Study of Oral ZL-65 Tablets in Healthy and Obese Participants With Cardiovascular RiskClinical18 NovShanghai Henlius Biotechtrial registered · A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX49 in Advanced/Metastatic Solid TumorsClinical18 NovSleep Cycle ABtrial registered · Development of the Sleep Cycle App's Tracking Abilities of Sleep and Sleep BehaviorsClinical17 NovAerys Biosciencestrial registered · First-in-Human Study of ABS-169 in Healthy VolunteersClinical17 NovAstraZenecatrial registered · A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCClinical17 NovNS Pharma, Inc.trial registered · A Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular DystrophyClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.